NDC Package 61755-013-01 Evkeeza

Evinacumab Injection, Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
Package Description:
Product Code:
Proprietary Name:
Non-Proprietary Name:
Substance Name:
Usage Information:
EVKEEZA is indicated as an adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 12 years and older, with homozygous familial hypercholesterolemia (HoFH).
11-Digit NDC Billing Format:
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2478648 - evinacumab-dgnb 345 MG in 2.3 ML Injection
  • RxCUI: 2478648 - 2.3 ML evinacumab-dgnb 150 MG/ML Injection
  • RxCUI: 2478648 - evinacumab-dgnb 345 MG per 2.3 ML Injection
  • RxCUI: 2478650 - Evkeeza 345 MG in 2.3 ML Injection
  • RxCUI: 2478650 - 2.3 ML evinacumab-dgnb 150 MG/ML Injection [Evkeeza]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Regeneron Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    FDA Application Number:
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    Listing Expiration Date:
    Exclude Flag:
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 61755-013-01?

    The NDC Packaged Code 61755-013-01 is assigned to a package of 1 vial, single-use in 1 carton / 2.3 ml in 1 vial, single-use of Evkeeza, a human prescription drug labeled by Regeneron Pharmaceuticals, Inc.. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

    Is NDC 61755-013 included in the NDC Directory?

    Yes, Evkeeza with product code 61755-013 is active and included in the NDC Directory. The product was first marketed by Regeneron Pharmaceuticals, Inc. on February 11, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 61755-013-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 61755-013-01?

    The 11-digit format is 61755001301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code